Phosplatin Therapeutics Announces Two Leadership Appointments

Scientific Advisory Board Member Dr. Joseph F. O'Donnell Steps in as Interim Chief Medical Officer; Jason Summa Joins in Newly Created Clinical Development Role NEW YORK, Sept. 9, 2020 -- (Healthcare Sales & Marketing Network) -- Phosplatin Therapeutic... Biopharmaceuticals, Oncology, Personnel Phosplatin Therapeutics, phosphaplatins
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news